HomeInsightsStock Comparison

Astrazeneca Pharma India Ltd vs Strides Pharma Science Ltd Stock Comparison

Astrazeneca Pharma India Ltd vs Strides Pharma Science Ltd Stock Comparison

Last Updated on: Jun 13, 2025

Key Highlights

  • The Latest Trading Price of Astrazeneca Pharma India Ltd is ₹ 10524 as of 13 Jun 15:30.
  • The P/E Ratio of Astrazeneca Pharma India Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Strides Pharma Science Ltd changed from 79.4 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years.
  • The Market Cap of Astrazeneca Pharma India Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Strides Pharma Science Ltd changed from ₹ 2888 crore on March 2020 to ₹ 7192 crore on March 2024 . This represents a CAGR of 20.01% over 5 years.
  • The revenue of Astrazeneca Pharma India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Strides Pharma Science Ltd for the Mar '25 is ₹ 1205 crore as compare to the Dec '24 revenue of ₹ 1160 crore. This represent the growth of 3.9%.
  • The ebitda of Astrazeneca Pharma India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Strides Pharma Science Ltd for the Mar '25 is ₹ 205.56 crore as compare to the Dec '24 ebitda of ₹ 214.45 crore. This represent the decline of -4.15%.
  • The net profit of Astrazeneca Pharma India Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Strides Pharma Science Ltd changed from ₹ -9.36 crore to ₹ 85.62 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Astrazeneca Pharma India Ltd changed from 3.46 % on March 2020 to 37.15 % on March 2024 . This represents a CAGR of 60.76% over 5 yearsThe Dividend Payout of Strides Pharma Science Ltd changed from 104.26 % on March 2020 to 35.08 % on March 2024 . This represents a CAGR of -19.58% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Astrazeneca Pharma India Ltd

  • AstraZeneca Pharma India Limited (APIL) was incorporated on July 11, 1979.
  • The Company is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and co-ordinates clinical trial services with an overseas group company.
  • The major therapy areas where the company operates are Onocology, Alimentary & Metabolism, Cardio Vascular, Renal, Diabetes, Respiratory and Oncology. AstraZeneca Pharma India, formerly known as Astra-IDL (AIL), was an erstwhile joint venture of Astra Zeneca, UK and Hinduja controlled IDL. Astra Pharmaceuticals AB, Sweden acquired all of the 1287500 equity shares in the Company of IDL, representing 25.75% of the Company's issued and paid up equity share capital.
  • Consequently, the Company became a subsidiary of Astra, which is a direct wholly owned subsidiary of Astra AB, Sweden (now known as AstraZeneca Pharmaceuticals AB Sweden) and an indirect wholly owned subsidiary of AstraZeneca Plc, the Group parent Company.

About Strides Pharma Science Ltd

  • Strides Pharma Science Limited was originally incorporated under the name 'Strides Arcolab Limited ' on June 28, 1990.
  • In FY 2016, Shasun Pharmaceuticals Limited merged with Strides Arcolab Limited forming a new identity 'Strides Shasun Limited', which became effective from 19 November, 2015 and name of the Company was changed to 'Strides Pharma Science Limited' from 'Strides Shasun Limited' effective on July 18, 2018. Strides Pharma Science is a global pharmaceutical company headquartered in Bengaluru, India.
  • The Company is an integrated manufacturer and exporter of Finished Pharmaceutical Dosage forms for both branded and generic.
  • It manufactures a very wide spectrum of ethical pharmaceutical products, OTC products and nutraceuticals.
  • Their dosage forms range includes tablets, capsules, soft gelatin capsules, parenterals and semisolids.

Astrazeneca Pharma India Ltd News Hub

News

AstraZeneca Pharma slides as MD Sanjeev Panchal steps down; Praveen Rao Akkinepally to take charge

Panchal is set to transition to a global role within the AstraZeneca Group, based in Gaith...

Read more

10 Jun 2025 09:49

News

Astrazeneca Pharma India Ltd Spurts 7.28%

Astrazeneca Pharma India Ltd gained 7.28% today to trade at Rs 8545.4. The BSE Healthcare ...

Read more

02 Jun 2025 09:30

News

AstraZeneca Pharma soars after Q4 PAT jumps 48% YoY

Profit before tax (PBT) stood at Rs 78.47 crore in Q4 FY25, up 44.35% year-on-year, and up...

Read more

02 Jun 2025 10:10

News

Volumes soar at Astrazeneca Pharma India Ltd counter

Max Healthcare Institute Ltd, Godrej Consumer Products Ltd, Mphasis Ltd, Indraprastha Gas ...

Read more

02 Jun 2025 11:00

News

Astrazeneca Pharma India Ltd leads gainers in 'A' group

Sun Pharma Advanced Research Company Ltd, Bank of Maharashtra, Reliance Power Ltd and Genu...

Read more

02 Jun 2025 12:00

News

Volumes spurt at Astrazeneca Pharma India Ltd counter

Niva Bupa Health Insurance Company Ltd, Indian Overseas Bank, Sterling & Wilson Renewable ...

Read more

02 Jun 2025 14:30

Strides Pharma Science Ltd News Hub

News

Board of Strides Pharma Science recommends final dividend

Strides Pharma Science announced that the Board of Directors of the Company at its meeting...

Read more

22 May 2025 18:03

News

Strides Pharma Science to announce Quarterly Result

Strides Pharma Science will hold a meeting of the Board of Directors of the Company on 22 ...

Read more

17 May 2025 11:40

News

Strides Pharma's US arm acquires four drugs to bolster portfolio

The portfolio consists of liquids and immediate release solid orals which are in the thera...

Read more

30 Apr 2025 07:51

News

Strides Pharma Science announces incorporation of step-down subsidiary

Arco Lab, a wholly owned subsidiary of Strides Pharma Science has incorporated a new wholl...

Read more

11 Apr 2025 15:34

News

Strides Pharma Science announces acquisition of Singapore-based Amexel

Strides Pharma Global (SPG), a step-down wholly-owned subsidiary of Strides Pharma Science...

Read more

15 Mar 2025 15:45

News

Strides Pharma Science appoints director

Strides Pharma Science has appointed Mukta Arora (DIN: 07225715) as Independent Director o...

Read more

31 Jan 2025 10:49

SWOT Analysis Of Strides Pharma Science Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Strides Pharma Science Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Astrazeneca Pharma India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Astrazeneca Pharma India Ltd and Strides Pharma Science Ltd

Which company has a larger market capitalization, Astrazeneca Pharma India Ltd or Strides Pharma Science Ltd?

Market cap of Astrazeneca Pharma India Ltd is 26,311 Cr while Market cap of Strides Pharma Science Ltd is 8,141 Cr

What are the key factors driving the stock performance of Astrazeneca Pharma India Ltd and Strides Pharma Science Ltd?

The stock performance of Astrazeneca Pharma India Ltd and Strides Pharma Science Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Astrazeneca Pharma India Ltd and Strides Pharma Science Ltd?

As of June 13, 2025, the Astrazeneca Pharma India Ltd stock price is INR ₹10524.65. On the other hand, Strides Pharma Science Ltd stock price is INR ₹883.4.

How do dividend payouts of Astrazeneca Pharma India Ltd and Strides Pharma Science Ltd compare?

To compare the dividend payouts of Astrazeneca Pharma India Ltd and Strides Pharma Science Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions